Latest news
Banco Comercial Português reports H1 2026 report and accounts filed - BitgetBitget · Fri, 07 Aug 2026 19:28:43 GMTHALOZYME THERAPEUTICS, INC. : LEERINK PARTNERS RAISES TO OUTPERFORM FROM MARKET PERFORM; RAISES TARGET PRICE TO $110 FROM $83 - BitgetBitget · Fri, 07 Aug 2026 14:59:35 GMTINSMED INC : GUGGENHEIM CUTS TARGET PRICE TO $205 FROM $207 - BitgetBitget · Thu, 06 Aug 2026 19:49:10 GMTBanco Comercial Português H1 FY26 net income rises 12.7% to EUR 565.8 million - BitgetBitget · Wed, 29 Jul 2026 07:00:00 GMT